TCL Archive In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General October 28, 1994
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014
TCL Archive Job Discrimination Survey Completed, But NCI Still Trying To Interpret I; Payments May Be Held Up August 19, 1977
